Entresto and Mirabegron drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Entresto (sacubitril; valsartan) and Mirabegron (mirabegron). Common drug interactions include escherichia bacteraemia among females and hypotension among males.
The phase IV clinical study analyzes what interactions people have when they take Entresto and Mirabegron. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Entresto?
Entresto has active ingredients of sacubitril; valsartan. eHealthMe is studying from 126,628 Entresto users. Check the latest studies of Entresto.
What is Mirabegron?
Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.
15 people who take Entresto and Mirabegron together, and have interactions are studied.

What are the common drug interactions of Entresto and Mirabegron, by gender? *:
female:
- Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
- Urinary tract infection
- Cardiac disorder
- Influenza
- Pyelonephritis (inflammation of kidney caused by bacteria)
male:
- Hypotension (abnormally low blood pressure)
- Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body)
- Cardiac failure
- Concomitant disease progression (progress in accompanying disease)
- Oedema peripheral (superficial swelling)
- Oxygen saturation decreased
- Spinal compression fracture (fracture due to spinal compression on bone)
- Bacterial infection
- Balance disorder
- Chronic gastritis (long lasting infection of stomach lining)
What are the common drug interactions of Entresto and Mirabegron, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Hypotension (abnormally low blood pressure)
- Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body)
- Oedema peripheral (superficial swelling)
- Oxygen saturation decreased
- Spinal compression fracture (fracture due to spinal compression on bone)
- Urinary tract infection
- Balance disorder
- Cold sweat
- Dizziness
- Feeling of despair
What are the existing conditions these people have? *
- Type 2 Diabetes: 3 people, 20.00%
- Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 20.00%
- High Blood Pressure: 3 people, 20.00%
- Dyslipidaemia (abnormal amount of lipids): 3 people, 20.00%
- Cardiac Failure Chronic: 3 people, 20.00%
- Cardiac Failure: 3 people, 20.00%
- Diabetes: 2 people, 13.33%
- Cardiac Disorder: 2 people, 13.33%
- Asthma: 2 people, 13.33%
- N-Terminal Prohormone Brain Natriuretic Peptide Increased: 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Entresto and Mirabegron?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Entresto (126,628 reports)
- Mirabegron (5,414 reports)
Browse all drug interactions of Entresto and Mirabegron:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Entresto:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Mirabegron:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Entresto and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mirabegron and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on sacubitril; valsartan and mirabegron (the active ingredients of Entresto and Mirabegron, respectively), and Entresto and Mirabegron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Aspirin and Sluggishness for Men aged 60+ - 3 seconds ago
- Could Tazidime cause Rhabdomyolysis? - 9 seconds ago
- Combivir and Pre-Eclampsia Aggravated for Women aged 30-39 - 10 seconds ago
- Could Fentanyl cause Peritoneal Haemorrhage? - 11 seconds ago
- Drug interactions of Midostaurin and Hydroxyurea - 12 seconds ago
- Neosar and Lovastatin drug interactions for women aged 50-59 - 18 seconds ago
- Lung Carcinoma Cell Type Unspecified Stage Iv and Idiopathic Pulmonary Fibrosis - 23 seconds ago
- Clonidine and Blood Creatinine Increased for Men aged 20-29 - 24 seconds ago
- Paroxysmal Nocturnal Haemoglobinuria and Thermal Burn - 24 seconds ago
- Gastric Ulcer and drugs of ingredients of belimumab - 24 seconds ago